Common Stock, Shares, Issued of Nascent Biotech Inc. from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Nascent Biotech Inc. quarterly Common Stock, Shares, Issued history and change rate from Q1 2014 to Q2 2024.
  • Nascent Biotech Inc. Common Stock, Shares, Issued for the quarter ending 30 Jun 2024 was 172,202,165, a 20% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

Nascent Biotech Inc. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2024 172,202,165 +28,565,387 +20% 30 Jun 2024 10-Q 14 Aug 2024 2025 Q1
Q1 2024 170,594,165 +38,829,817 +29% 31 Mar 2024 10-Q 14 Aug 2024 2025 Q1
Q4 2023 168,729,565 +46,683,393 +38% 31 Dec 2023 10-Q 14 Feb 2024 2024 Q3
Q3 2023 166,735,430 +48,540,346 +41% 30 Sep 2023 10-Q 09 Nov 2023 2024 Q2
Q2 2023 143,636,778 +26,571,103 +23% 30 Jun 2023 10-Q 18 Aug 2023 2024 Q1
Q1 2023 131,764,348 +20,451,173 +18% 31 Mar 2023 10-K 01 Jul 2024 2024 FY
Q4 2022 122,046,172 +14,317,997 +13% 31 Dec 2022 10-Q 14 Feb 2023 2023 Q3
Q3 2022 118,195,084 +10,466,909 +9.7% 30 Sep 2022 10-Q 10 Nov 2022 2023 Q2
Q2 2022 117,065,675 +9,337,500 +8.7% 30 Jun 2022 10-Q 09 Aug 2022 2023 Q1
Q1 2022 111,313,175 +6,479,092 +6.2% 31 Mar 2022 10-K/A 03 Jul 2023 2023 FY
Q4 2021 107,728,175 +16,398,021 +18% 31 Dec 2021 10-Q 14 Feb 2022 2022 Q3
Q3 2021 107,728,175 +40,547,484 +60% 30 Sep 2021 10-Q 04 Nov 2021 2022 Q2
Q2 2021 107,728,175 +44,934,568 +72% 30 Jun 2021 10-Q 12 Aug 2021 2022 Q1
Q1 2021 104,834,083 +59,943,821 +134% 31 Mar 2021 10-K 15 Jun 2022 2022 FY
Q4 2020 91,330,154 +55,369,284 +154% 31 Dec 2020 10-Q 09 Feb 2021 2021 Q3
Q3 2020 67,180,691 +33,407,721 +99% 30 Sep 2020 10-Q 16 Nov 2020 2021 Q2
Q2 2020 62,793,607 +29,298,137 +87% 30 Jun 2020 10-Q 07 Aug 2020 2021 Q1
Q1 2020 44,890,262 +12,243,627 +38% 31 Mar 2020 10-K 08 Jul 2021 2021 FY
Q4 2019 35,960,870 +4,821,272 +15% 31 Dec 2019 10-Q 11 Feb 2020 2020 Q3
Q3 2019 33,772,970 +3,240,113 +11% 30 Sep 2019 10-Q 18 Nov 2019 2020 Q2
Q2 2019 33,495,470 +4,952,175 +17% 30 Jun 2019 10-Q 13 Aug 2019 2019 Q1
Q1 2019 32,646,635 +4,893,270 +18% 31 Mar 2019 10-K 22 Jun 2020 2020 FY
Q4 2018 31,139,598 +3,877,792 +14% 31 Dec 2018 10-Q 13 Feb 2019 2019 Q3
Q3 2018 30,532,857 +3,401,081 +13% 30 Sep 2018 10-Q 05 Nov 2018 2019 Q2
Q2 2018 28,543,295 +4,496,606 +19% 30 Jun 2018 10-Q 06 Aug 2018 2019 Q1
Q1 2018 27,753,365 +4,461,067 +19% 31 Mar 2018 10-K 12 Jul 2019 2019 FY
Q4 2017 27,261,806 +5,383,391 +25% 31 Dec 2017 10-Q 31 Jan 2018 2018 Q3
Q3 2017 27,131,776 +5,286,661 +24% 30 Sep 2017 10-Q 03 Nov 2017 2018 Q2
Q2 2017 24,046,689 +2,262,624 +10% 30 Jun 2017 10-Q 09 Aug 2017 2018 Q1
Q1 2017 23,292,298 +1,674,733 +7.7% 31 Mar 2017 10-K 29 Jun 2018 2018 FY
Q4 2016 21,878,415 +477,300 +2.2% 31 Dec 2016 10-Q 09 Feb 2017 2017 Q3
Q3 2016 21,845,115 +883,963 +4.2% 30 Sep 2016 10-Q 09 Nov 2016 2017 Q2
Q2 2016 21,784,065 +3,719,465 +21% 30 Jun 2016 10-Q 09 Aug 2016 2017 Q1
Q1 2016 21,617,565 +4,052,965 +23% 31 Mar 2016 10-K 29 Jun 2017 2017 FY
Q4 2015 21,401,115 +4,091,515 +24% 31 Dec 2015 10-Q 19 Feb 2016 2016 Q3
Q3 2015 20,961,152 30 Sep 2015 10-Q 05 Nov 2015 2016 Q2
Q2 2015 18,064,600 30 Jun 2015 10-Q 30 Jul 2015 2016 Q1
Q1 2015 17,564,600 +10,564,400 +151% 31 Mar 2015 10-K 14 Jul 2016 2016 FY
Q4 2014 17,309,600 31 Dec 2014 10-Q 13 Feb 2015 2015 Q3
Q1 2014 7,000,200 31 Mar 2014 10-K 02 Jul 2015 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.